Fundraising FoxFirst Bight Ventures — 2021 Investments
2 investments dated 2021 · listed companies and verified rows first · show all
Persephone Biosciences develops live biotherapeutic products that modulate the metabolism of gut microbes for disease prevention and treatment, with a focus on cancer.
BiotechConsumerDeep TechDigital HealthFemTechHealthtechSan Diego, US
Stephen Van Dien(CTO)inStephanie Culler(CEO)in
Co-investorsPropel Bio PartnersBioBritFifty YearsHemi Ventures, LlcOcampo CapitalPioneer+13 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Proxifile
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.